ANIP Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 birž. 2024 @ 23:00):
Our systems believe the stock currently is undervalued by 0.07% compare to its pairs and should correct upwards.

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada...

Stats
Šios dienos apimtis	675 471
Vidutinė apimtis	151 629
Rinkos kapitalizacija	1.33B
EPS	$0.840 ( Q1 \| 2024-05-10 )
Kita pelno data	( $0 ) 2024-08-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	39.55 (Sector) 42.63 (Industry) 0
ATR14	$0.0890 (0.14%)

ACOR -24.02%

ACRX 7.50%

ADMP 0.85%

ADMS 0.00%

AGRX -1.40%

AKAN -3.75%

ALIM 0.54%

AMPH -0.87%

AMYT 0.00%

ANIP 0.94%

AQST 0.39%

ASRT -5.34%

ATNX 0.00%

AVDL -1.75%

AYTU 0.00%

BFRI -2.39%

BGXX -34.22%

CLVR -2.22%

COLL -0.74%

CPIX 0.66%

CRDL 1.00%

CRON -0.43%

CYTH 5.83%

DCPH 0.00%

DERM 9.73%

DRRX -5.49%

DVAX -1.23%

EGRX 11.55%

EMBC 0.32%

EMBCV -9.33%

EOLS -0.73%

ESPR -3.90%

EVOK 5.48%

FLGC 6.71%

FLXN 0.00%

GHSI -0.35%

HCM -1.83%

HROW -0.52%

HUGE -4.71%

IMCC 2.20%

INCR 2.03%

IRWD 5.16%

ITCI -3.51%

IXHL 10.53%

JUPW 11.76%

KALA 9.92%

KIN 0.11%

KMDA -1.78%

LNTH -1.25%

NBIX 2.50%

NEPT 0.00%

NLTX 1.45%

OGI -3.75%

OPTN -3.70%

ORGO 6.06%

PAHC -2.50%

PCRX 2.51%

PETQ -0.45%

PLXP 0.00%

PPD 0.00%

PROC -0.40%

PRPH -2.11%

PTPI 2.69%

RDHL -2.58%

RDUS 4.30%

REPH -0.48%

RGC -5.88%

RMTI 0.00%

SCTL 0.92%

SCYX -1.48%

SIGA 3.13%

SISI -13.33%

SNDL -1.04%

SNOA 1.05%

SSIC 1.03%

SUPN -0.45%

SXTC -2.24%

THTX 0.00%

TKNO -1.44%

TLGT -13.85%

TLRY -4.05%

TXMD -7.47%

TYHT -3.90%

UPC -1.97%

VTRS 1.43%

ZYNE 2.36%

Insider Trading

Date	Person	Action	Amount	type
2024-06-21	Shanmugam Muthusamy	Sell	20 000	Common Stock
2024-06-17	Shanmugam Muthusamy	Sell	7 946	Common Stock
2024-06-18	Shanmugam Muthusamy	Sell	10 607	Common Stock
2024-06-20	Shanmugam Muthusamy	Sell	11 447	Common Stock
2024-06-13	Cook Meredith	Sell	250	Common Stock

INSIDER POWER
-27.42
Last 100 transactions
Buy: 371 183 \| Sell: 622 427

Koreliacija (AI algo v.1.1b): Undervalued: 0.07% $63.72 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: 0.00 (neutral)

Trumpas: 0.53 (weak)

Signal:(60.863) Neutral

ANI Pharmaceuticals Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
OZEM	1
REBN	0.944
MMUKX	0.94
TRVI	0.937
KARRX	0.937
PRUAX	0.933
PRUZX	0.933
FIUIX	0.932
NALFX	0.927
BDGS	0.927

10 Labiausiai neigiamai susiję koreliacijos
SABR	-0.95
MFIN	-0.928
CYAN	-0.924
CLMB	-0.917
SOFO	-0.912
DPRO	-0.905
BRLSW	-0.904
AMCX	-0.9
ACON	-0.898
AAPD	-0.896

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

ANI Pharmaceuticals Inc Koreliacija - Valiuta/Žaliavos

0.62
( weak )

0.23
( neutral )

0.78
( moderate )

0.74
( moderate )

0.54
( weak )

-0.78
( moderate negative )

ANI Pharmaceuticals Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$486.82M
Bruto pelnas:	$245.51M (50.43 %)
EPS:	$0.950

FY	2023
Pajamos:	$486.82M
Bruto pelnas:	$245.51M (50.43 %)
EPS:	$0.950

FY	2022
Pajamos:	$316.39M
Bruto pelnas:	$177.60M (56.13 %)
EPS:	$-2.95

FY	2021
Pajamos:	$216.14M
Bruto pelnas:	$115.53M (53.45 %)
EPS:	$-5.81

Financial Reports:

No articles found.

ANI Pharmaceuticals Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.